メディキット reported ordinary income (loss) of ¥2,557 million for the first half of the fiscal year ending March 2027, 18.9% above the prior forecast of ¥2,150 million. Full-year ordinary income (loss) is forecast at ¥4,400 million, unchanged from the previous forecast.
According to メディキット's first-half results for the fiscal year ending March 2027, announced on 12 November, ordinary income (loss) was ¥2,557 million. This was well above the company's prior forecast of ¥2,150 million.
The full-year earnings forecast announced the same day calls for ordinary income (loss) of ¥4,400 million, unchanged from the previous forecast. Despite first-half results exceeding the market forecast, the full-year outlook continues to call for lower earnings.
Related stocks cited include Nikon, Nagano Keiki, Tokyo Seimitsu and Oval. The news was reported as being provided by iFIS Japan.